triglycerides: nootropics and compounds | sci-wiki

Dihydroberberine

Dihydroberberine (DHB) is a reduced, or hydrogenated, form of berberine; basically the same molecule with two extra hydrogen atoms tacked on. Once it hits the gut it gets converted right back to berberine, so you end up with all the familiar berberine effects (blood sugar control, better lipids, AMPK activation) but from a much smaller dose. The whole reason DHB exists is absorption. Plain berberine is notoriously hard to get into the bloodstream, so DHB is the clever workaround. Think of it as the same engine with a better fuel line; nothing new downstream, just far more of it actually reaching your cells. People reach for it for the same goals as berberine: steadier blood sugar, improved insulin sensitivity, healthier cholesterol and triglycerides, and that "exercise in a pill" AMPK effect on the cell's energy machinery.

1 outlet

Supplement

Vitamin B3 (Niacin)

Vitamin B3 is an essential water-soluble nutrient that exists in two main forms, nicotinic acid (niacin) and nicotinamide (niacinamide), both of which the body converts into the coenzymes NAD+ and NADP+ that drive hundreds of redox reactions in energy metabolism. A prolonged dietary lack causes pellagra, the deficiency disease classically remembered by the "three Ds" of dermatitis, diarrhea, and dementia. In pharmacologic doses nicotinic acid favorably shifts blood lipids (raising HDL while lowering LDL, triglycerides, and lipoprotein(a)) and produces the characteristic warm "niacin flush," whereas nicotinamide has neither the flush nor the lipid effects and is used mainly in dermatology. It is distinct from the dedicated NAD-boosting precursors nicotinamide riboside (NR) and NMN, which are covered in their own entries.

2 outlets

Cardiovascular

Fenofibrate

Fenofibrate is a lipid-lowering medication of the fibrate class, used mainly to reduce high triglyceride levels and to manage mixed dyslipidemia. It is a prodrug that the body converts to its active form, fenofibric acid, which switches on a receptor called PPAR-alpha to change how the body handles fats. Sold under brand names such as Tricor, it is taken by mouth and is often combined with a statin.

1 outlet

Supplement

Icosapent Ethyl

Icosapent ethyl is a prescription omega-3 medication, the ethyl ester of eicosapentaenoic acid (EPA), a fatty acid found in fish oil. Unlike ordinary fish-oil supplements it is a highly purified form containing only EPA and no DHA. Sold under the brand Vascepa, it is used to lower very high triglycerides and, in people already on statins, to reduce the risk of cardiovascular events.

1 outlet

Cardiovascular

Saroglitazar

Saroglitazar is an oral dual PPAR-alpha and PPAR-gamma agonist of the glitazar class, developed in India for metabolic disorders. It is used mainly to treat diabetic dyslipidemia and hypertriglyceridemia, and it has been studied for non-alcoholic fatty liver disease and related conditions. By activating two nuclear receptor subtypes it lowers blood triglycerides while also improving insulin resistance and blood sugar.

1 outlet

Cardiovascular

Acipimox

Acipimox is a synthetic derivative of nicotinic acid (niacin) used as a lipid-lowering medication. It is prescribed mainly to lower elevated triglycerides and, to a lesser degree, to raise HDL cholesterol in people with certain forms of hyperlipidemia. Marketed in parts of Europe under the trade name Olbetam, it is generally regarded as having a milder side-effect profile than niacin itself.

reference

PPAR Modulator

Pemafibrate

Pemafibrate is a selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) used as an oral lipid-lowering medicine, chiefly to reduce elevated blood triglycerides. It belongs to the fibrate family of drugs but was engineered to bind the PPARα receptor with greater potency and selectivity than older fibrates, with the aim of improving the balance between benefit and adverse effects. Developed by the Japanese company Kowa and marketed as Parmodia, it was first approved in Japan in 2017.

reference